When alliances fail, is arbitration the answer?
The global pandemic has increased collaboration and a new wave of disputes is likely. Arbitration is well placed to help, argue Kate Davies McGill, Gaela Gehring Flores and Paul Keller of Allen & Overy
- Clearing a way through the CRISPR patent jungle 08-05-2018
- LSIPR 50 2017: Yoshinori Ohsumi 10-11-2017
- IP service providers: a more cost-effective solution post M&A? 18-10-2016
- Technology transfer: A smart way of working 14-10-2016
- Working together wisely 12-10-2016
Latest asia-pacific news
J&J pledges not to enforce TB patents in certain countries
03-10-2023
Non-profit hails move but urges other big pharma companies to follow suit | To avoid litigation, manufacturers must ensure generic versions are of good quality, medically acceptable, and are used only in the selected low-and middle-income countries.